z-logo
Premium
Chromophore‐Modified Highly Selective Ratiometric Upconversion Nanoprobes for Detection of ONOO − ‐Related Hepatotoxicity In Vivo
Author(s) -
Liu Xiao,
Lai Huanhua,
Peng Juanjuan,
Cheng Dan,
Zhang XiaoBing,
Yuan Lin
Publication year - 2019
Publication title -
small
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.785
H-Index - 236
eISSN - 1613-6829
pISSN - 1613-6810
DOI - 10.1002/smll.201902737
Subject(s) - photon upconversion , peroxynitrite , in vivo , fluorescence , chromophore , luminescence , nanoparticle , nanotechnology , materials science , chemistry , photochemistry , optoelectronics , biochemistry , optics , biology , physics , microbiology and biotechnology , enzyme , superoxide
Acute hepatitis is a major problem affecting public health and has attracted more and more attention. Generally, as the standard means, blood tests are taken for evaluating hepatitis. However, such tests fail to accurately reflect the level of hepatitis in vivo. Herein, two highly selective ratiometric fluorescent probes are designed to track peroxynitrite (ONOO − ) as the hepatitis indicator, and further evaluate acute liver injury in vivo through dye‐grafted upconversion nanoparticles (UCNPs). Specifically, upconversion luminescence of nanoprobes at 540 or 660 nm can be quenched by the designed and synthesized chromophore E‐CC or H‐CC, that can be destroyed by ONOO − via energy transfer (ET) process, while the upconversion luminescence intensity at 810 nm remains the same. Thus, the developed nanoprobes can be used for ratiometric detection ( I 540 / I 660 or I 660 / I 810 ) of ONOO − . Moreover, the developed near infrared ratiometric nanoprobes can highly selectively detect ONOO − , which can eliminate the interference of HOCl and SO 3 2− . Finally, it is demonstrated that this highly selective ratiometric nanosystem can achieve effective detection of ONOO − in living cells and CCl 4 ‐induced acute liver injury models. It provides some reference value for clinical detection of hepatotoxicity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here